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Relation Between Leisure Time, Commuting, and Occupational
Physical Activity With Blood Pressure in 125 402 Adults: The Lifelines
Cohort
Oyuntugs Byambasukh, MD; Harold Snieder, PhD; Eva Corpeleijn, PhD
Background-—Whether all domains of daily-life moderate-to-vigorous physical activity (MVPA) are associated with lower blood
pressure (BP) and how this association depends on age and body mass index remains unclear.
Methods and Results-—In the population-based Lifelines cohort (N=125 402),MVPAwas assessed by theShortQuestionnaire toAssess
Health-Enhancing Physical Activity, a validated questionnaire in different domains such as commuting, leisure-time, and occupational PA.
BP was assessed using the last 3 of 10 measurements after 10 minutes’ rest in the supine position. Hypertension was defined as systolic
BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg and/or use of antihypertensives. In regression analysis, higher commuting and leisure-
time but not occupational MVPA related to lower BP and lower hypertension risk. Commuting-and-leisure-timeMVPA was associated with
BP in a dose-dependentmanner. b Coefficients (95% CI) from linear regression analyses were1.64 (2.03 to1.24),2.29 (2.68 to
1.90), and finally2.90 (3.29 to2.50)mm Hgsystolic BP for the low,middle, and highest tertile ofMVPAcomparedwith “NoMVPA”
as the reference group after adjusting for age, sex, education, smokingandalcohol use. Further adjustment for bodymass index attenuated
the associations by 30% to 50%, but more MVPA remained significantly associated with lower BP and lower risk of hypertension. This
associationwasagedependent.bCoefficients (95%CI) for thehighest tertiles of commuting-and-leisure-timeMVPAwere1.67 (2.20 to
1.15),3.39 (3.94 to2.82) and4.64 (6.15 to3.14) mm Hg systolic BP in adults <40, 40 to 60, and >60 years, respectively.
Conclusions-—Higher commuting and leisure-time but not occupational MVPA were significantly associated with lower BP and
lower hypertension risk at all ages, but these associations were stronger in older adults. ( J Am Heart Assoc. 2020;9:e014313.
DOI: 10.1161/JAHA.119.014313.)
Key Words: blood pressure • commuting activity • domain-specific physical activity • hypertension • leisure-time activity •
occupational activity
H ypertension is one of the most common disorders in thegeneral population, with 90% of lifetime risk for elderly
individuals.1 Previous meta-analyses have indicated that
exercise training is a relatively cost-effective intervention in
the management of hypertension, even more so than
pharmacological treatment.2,3 However, little is known about
the potential benefits of different domains of daily-life physical
activity on blood pressure, especially from large population-
based studies.4,5 In addition, a growing body of evidence is
showing that occupational physical activity (OPA) has no
benefit on health.4,6,7 Therefore, one critical step in exploring
benefits of physical activity on blood pressure is to evaluate
its benefit across the major domains of daily-life activities.
Previous studies have tended to focus on the benefit of
leisure-time physical activity on reducing the risk of hypertension
and lowering blood pressure (BP).2,3,8,9 However, only a few
observational studies have attempted to explore the impact of
other domains, mostly with small sample sizes.4,5 A meta-
analysis reported that OPA does not reduce the risk of
hypertension.4 However, a recent study showed that OPA lowers
the risk of mortality in patients with high BP.10 Furthermore,
several studies have shown that active transportation (commut-
ing) is beneficial for reducing the risk of hypertension, but others
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have found no association.5,6,10 Another issue is that although
OPA and commuting physical activity are the major contributors
to total daily-life physical activity, these domains are not
differentiated in the clinical guidelines11,12 but may be an
important attribute of relevance similar to intensity and duration.
Therefore, there is a need to investigatewhether domain-specific
physical activity confers the same impact on BP and the risk of
having hypertension. We describe the following domains in this
study: leisure time, commuting, and occupational. Physical
activities in the leisure-time domain refer to activities that are
chosen for pleasure or relaxation such as walking, cycling, and
sports. Commuting physical activity is considered as the activity
to travel between the place of residence and work or study.
Occupational activity refers to activities that are done on
purpose, related to one’s occupation.
The aim of this study was to investigate the associations of
different domains of daily-life physical activity, such as
commuting, leisure-time, and occupational, with BP level
and the risk of having hypertension. Furthermore, it was
studied whether the associations depend on body mass index
(BMI) categories and on age over the life course in a large
cohort representative of the general population.
Materials and Methods
Data Source and Study Population
Lifelines is a multidisciplinary, prospective, population-based
cohort and bio-bank of more than 167 000 people living in
the north of the Netherlands. It employs a broad range of
investigative procedures in assessing the biomedical, sociode-
mographic, behavioral, physical, and psychological factors
that contribute to the health and disease of the general
population, with a special focus on multimorbidity and
complex genetics. Participants were recruited via general
practitioners; subsequently, family members were invited to
participate; and, finally, adults could self-register to partici-
pate. The Lifelines cohort does not enable public data sharing.
The cohort’s data are available only to researchers who, upon
approval of a submitted research proposal, have signed a
Data/Material Transfer Agreement. The study was conducted
according to the Helsinki Declaration and was approved by
the medical ethical review committee of the University
Medical Center Groningen, the Netherlands. All participants
provided their written informed consent.13,14
In this cross-sectional study of the adult subsample (18–
93 years) of the Lifelines cohort, we included subjects of
Western European origin.15 Participants who had missing data
needed to evaluate BP parameters: systolic BP (SBP) and
diastolic BP (DBP) and to assess physical activity were
excluded. We also excluded pregnant women in this study.
Furthermore, participants with a history of coronary heart
disease, stroke, heart failure, and renal failure and partic-
ipants who had implausible data related to physical activity
measurement (time spent in activities listed in the Short
Questionnaire to Assess Health-Enhancing Physical Activity
[SQUASH] ≥18 h/day)16 were excluded. A total of 125 402
participants were included in the current analysis (Figure S1).
Assessment of Physical Activity
Physical activity was assessed using the SQUASH, a ques-
tionnaire estimating habitual physical activities, referring to a
normal week.17 Questions for each reported activity consist of
3 main parts: days per week (frequency), average time per day
(duration), and effort. Each activity in minutes per week was
calculated by multiplying frequency (days/week) by duration
(min/day). Then, the activities were assigned to a certain level
of intensity, indicated by the metabolic equivalent of task
(MET) value of the activity.17,18 MET values were assigned to
all activities in the questionnaire with the help of Ainsworth’s
Compendium of Physical Activities 2011.19 Using these MET
values in combination with the reported efforts, as explained
in the study of Wendel-Vos et al,18 each activity in minutes
per week were classified into light (<4.0 MET), moderate (4.0
to <6.5 MET), and vigorous (≥6.5 MET) intensity. The SQUASH
questionnaire has been validated in the general population.17
In this study, we used activity minutes per week only at the
moderate-to-vigorous level in different domains such as
commuting, leisure-time, and occupational. Total minutes for
each domain-specific moderate-to-vigorous physical activity
Clinical Perspective
What Is New?
• Benefit of daily-life moderate-to-vigorous physical activity on
blood pressure depends on the domain of physical activity,
be it leisure time, commuting, or occupational, and higher
levels of occupational activity are not directly associated
with lower blood pressure the same way that leisure-time or
commuting physical activity is.
• The potentially favorable effect of commuting and leisure-
time physical activity were independent of body mass index
categories.
• By being more active at commuting and leisure-time
domains, older individuals have a relatively larger reduction
in systolic blood pressure or pulse pressure than younger
adults.
What Are the Clinical Implications?
• The domain of daily-life physical activity may be an
important attribute and should potentially be recommended
in the clinical guidelines for hypertension, similarly to
intensity and duration.
DOI: 10.1161/JAHA.119.014313 Journal of the American Heart Association 2
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(MVPA) were calculated by summing up the all MVPA minutes
for domain-related activities. For instance, leisure-time MVPA
was the sum of MVPA minutes per week in leisure time
walking, cycling, gardening, doing odd jobs around the house,
and sports. In addition, total daily-life MVPA was calculated by
the sum of all domain-specific MVPA: commuting, leisure-time
and occupational. Furthermore, leisure-time MVPA was com-
bined with commuting MVPA, as active commuting of high
intensity and longer duration is often replacing sports
activities, like cycling, in the setting of the Netherlands.
Finally, total and each domain-specific (total physical activity,
commuting-and-leisure-time physical activity, commuting
physical activity, leisure-time physical activity, and occupa-
tional physical activity) MVPA minutes per week were
classified as one of the following categories separately: “No
MVPA” (the people who did not perform physical activity at a
moderate-to-vigorous level) and tertiles of MVPA from low
(tertile 1, MVPA-T1), middle (tertile 2, MVPA-T2) to high
(tertile 3, MVPA-T3). Thus, T0, T1, T2, and T3 were considered
as “inactive,” “not very active,” “active,” and “very active,”
respectively.
BP and Hypertension
BP parameters were obtained with an automated device
(DinaMap, PRO 100V2, GE Healthcare, Freiburg, Germany) in
a quiet room with room temperature after 10 minutes’ rest in
the supine position.13,14 The size of the cuff was chosen
according to the arm circumference. Ten measurements were
taken in a period of 10 minutes. The average of the final 3
readings was used for each BP parameter (systolic and
diastolic). Pulse pressure was calculated as the difference
between systolic and diastolic BP.
Hypertension was defined as SBP ≥140 mm Hg and/or
DBP ≥90 mm Hg and/or use of antihypertensive medication.
The definition of medication use was based on Anatomical
Therapeutic Chemical codes using recorded medication data:
C02 (antihypertensives), C03 (diuretics), C07 (b-blocking
agents), C08 (calcium channel blockers) and C09 (agents
acting on the renin-angiotensin system).12,20
Other Measurements and Definitions
Body weight and height were measured to calculate BMI as
the ratio between weight (kilograms) and the square of height
(meters). Blood samples were collected in the fasting state
and analyzed on the day of collection at the Department of
Laboratory Medicine of the University Medical Center Gronin-
gen, the Netherlands (Data S1).13,14
Education level was categorized as low, medium, or high
(Data S1). Current smoking was categorized as nonsmokers
or smokers. From the Food Frequency Questionnaire, daily
caloric intake and alcohol intake were calculated and
presented as kilocalories per day and grams of alcohol per
day. Definitions for cardiovascular diseases, renal failure, and
type 2 diabetes mellitus are described in Data S1.
Statistical Analysis
General characteristics were expressed as means with an SD
for normally distributed variables, medians with interquartile
range (25th–75th percentile) for non–normally distributed
variables or numbers with percentages for categorical
variables in total, normotensive, and hypertensive partici-
pants. The differences between normo- and hypertensive
participants were compared using regression analyses with
age and sex as covariates (adjusted P values were reported).
Linear regression analysis was performed to evaluate the
association between MVPA and BP parameters including SBP
and DBP, and pulse pressure. In this analysis, we created
dummy exposure variables for each physical activity domain
for comparison between the reference group (No MVPA) and
tertiles of MVPA at each domain (T1-3). Outcomes were
presented as unstandardized b coefficients with 95% CIs.
Furthermore, binary logistic regression analysis was used to
calculate odds ratios for risk of having hypertension associ-
ated with MVPA categories (tertiles of each domain) versus
the “No MVPA” (inactive) category. In the regression analyses,
the basic model was adjusted for age, square of age (because
age may be nonlinearly related to outcome), sex, and
education. In Model 1, we added current smoking (yes/no)
and alcohol consumption (g/day) as potential lifestyle con-
founders to the basic model. Model 2 was adjusted for BMI in
addition to Model 1. In linear regression analyses, the effect
of medication was corrected by adding 15 and 10 mm Hg to
SBP and DBP, respectively, for participants who reported
using antihypertensives (10.8%).21 All the regression analyses
were repeated for different age categories (<40, 40–60, and
>60 years) and BMI categories (BMI <25 kg/m2, 25–30 kg/
m2, and >30 kg/m2). Interaction effects were also tested with
age and BMI separately in the association of physical activity
with outcome variables.
As mentioned above, BP was corrected for the use of
antihypertensive medication in the main analysis. In a
sensitivity analysis, we compared the b coefficients from
linear regression analyses to adjust for medication use in
different ways, first, using the uncorrected BP, and then
looking into the association of physical activity with BP in 2
groups according to hypertensive status (normotensive and
hypertensive). In this analysis, we adjusted for age, square of
age, sex, education, smoking, and alcohol use. Thereafter, we
additionally adjusted for antihypertensive medication use in
the group with hypertension, using a term for medication
effect in the association between physical activity and BP.
DOI: 10.1161/JAHA.119.014313 Journal of the American Heart Association 3


















 http://ahajournals.org by on M
arch 3, 2020
All statistical analyses were carried out using SPSS version
22.0 (IBM, Chicago, IL) and Prism version 4.03 (GraphPad
Software, La Jolla, CA). A 2-sided statistical significance was
set at P<0.05 for all tests.
Results
The number of hypertensive people accounted for 24.4% of
the total population. Hypertensive people were older, more
frequently men with lower education levels, more likely to
have diabetes mellitus, and less frequently smokers. Fur-
thermore, daily caloric intake and alcohol consumption were
higher in the hypertensive group. Hypertensive people had a
larger waist circumference and higher BMI. Finally, higher
concentrations of total cholesterol, low-density lipoprotein
cholesterol, and fasting plasma glucose and lower concen-
tration of high-density lipoprotein cholesterol were observed
in hypertensives compared with normotensives (all
P<0.0001) (Table 1). The mean of SBP steadily increased
with age, while DBP no longer increased in the older age
group (>40 y, Figure S2). According to the level of physical
activity, people in all inactive groups at leisure-time and
commuting activities had higher BMI and higher concentra-
tions of total cholesterol and triglycerides and were more
likely to have diabetes mellitus compared with the highest
tertiles of each domain (Table S1). Conversely, a higher BMI
and a higher concentration of triglycerides were noted in the
group with the highest level of occupational physical activity
compared with the inactive group. Moreover, they were more
frequently smokers and had a higher consumption of alcohol
intake. Furthermore, we stratified level of daily-life physical
activities according to age (Figure S3). This shows that older
adults performed more moderate activities such as nonsport
leisure-time activities, while more vigorous activities are
noted in younger adults.
In regression analysis, higher commuting and leisure-time,
but not occupational MVPA were associated with lower BP
(basic model, Figure 1). The associations remained materi-
ally unchanged after adjustments for other potential
Table 1. General Characteristics of the Study Population
Variable Total (n=125 402) Normotensive (n=94 760) Hypertensive (n=30 642) P Value
Age, y 45 (36–51) 42 (33–49) 49 (43–60) <0.0001
Male sex, % (n) 40.5 (50 762) 38.8 (32 930) 44.1 (17 832) <0.0001
Education: low, % (n) 27.7 (34 758) 23.8 (20 185) 36.0 (14 573) <0.0001*
Current smoking, % (n) 21.2 (26 553) 22.5 (19 104) 18.4 (7449) <0.0001*
Alcohol use, (gr/day) 3.87 (0.86–10.3) 3.84 (0.97–9.86) 3.91 (0.72–11.65) <0.0001*
Daily caloric intake (kcal/day) 1995.4616.8 1956.5606.4 2012.8620.6 <0.0001*
BMI (kg/m2) 26.04.3 25.23.9 27.74.6 <0.0001*
Waist in men (cm) 95.0 10.8 92.69.9 99.410.8 <0.0001*
Waist in women (cm) 86.612.2 84.411.2 91.612.9 <0.0001*
SBP (mm Hg) 125.315.2 119.810.4 142.115.4 NA
DBP (mm Hg) 73.79.3 71.27.4 81.510.3 NA
Pulse pressure (mm Hg) 51.611.0 48.78.5 60.612.9 NA
Total cholesterol (mmol/L) 5.081.00 4.990.97 5.281.01 0.114*
Triglyceride (mmol/L) 1.170.81 1.080.71 1.360.95 <0.0001*
HDL-C in men (mmol/L) 1.310.32 1.330.31 1.280.32 <0.0001*
HDL-C in women (mmol/L) 1.620.40 1.630.39 1.590.40 <0.0001*
LDL-C (mmol/L) 3.230.91 3.150.90 3.420.92 0.001*
FPG (mmol/L) 4.990.81 4.890.68 5.231.01 <0.0001*
Diabetes mellitus, % (n) 3.0 (3766) 1.4 (1157) 6.4 (2609) <0.0001*
Total MVPA (min/week) 310 (120–770) 325 (130–796) 300 (120–720) <0.0001*
No MVPA, % (n) 9.9 (12 408) 9.1 (7871) 11.7 (4537) <0.0001*
Data are presented as meanSD or median (25th–75th percentile) and number (%). BMI indicates body mass index; BP, blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma
glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MVPA, moderate-to-vigorous physical activity; NA, not applicable; SBP, systolic blood
pressure.
*Adjusted for age and sex.
DOI: 10.1161/JAHA.119.014313 Journal of the American Heart Association 4
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confounders (Model 1, Table S2). Only leisure-time MVPA
was associated with BP in a dose-dependent manner. b
Coefficients (95% CI) were 1.25 (1.60 to 0.89), 1.85
(2.22 to 1.49) and 2.25 (2.61 to 1.89) mm Hg for
SBP and 0.62 (0.84 to 0.39), 0.87 (1.10 to 0.64)
and 1.23 (1.46 to 1.01) mm Hg for DBP for the low,
middle, and highest tertile of MVPA, respectively, compared
with “No MVPA” in the leisure-time domain as the reference
group. The combined effect of commuting and leisure-time
MVPA together was stronger than for individual domains or
total daily-life MVPA (Figure 1 and Table 2). This combined
time of 2 domains will be presented and named as
“commuting-and-leisure-time” in later sections. Furthermore,
commuting-and-leisure-time MVPA was dose-dependently
associated with lower pulse pressure. In logistic regression
analysis, likewise, leisure-time MVPA was dose-dependently
associated with lower hypertension risk (Table S3). In
contrast, commuting MVPA tertiles did not show dose-
dependent associations. Compared with “No MVPA” of each
domain, the odds ratios (95% CI) for the highest tertiles of
commuting and leisure-time MVPA were 0.78 (0.73–0.83)
and 0.74 (0.70–0.79), respectively. Furthermore, dose-
dependent risk reduction was observed when combining
commuting and leisure-time activities but not when occupa-
tional MVPA was included in total MVPA. The odds ratios
(95% CI) for commuting-and-leisure-time MVPA tertiles were
0.82 (0.77–0.87), 0.73 (0.69–0.78), and 0.69 (0.65–0.74)
compared with No MVPA.
Further adjustment for BMI attenuated the associations by
30% to 50%. Both commuting and leisure-time MVPA domains
remained significantly associated with BP and hypertension
risk, independent of BMI (Model 2, Table S2). There was no
significant interaction between commuting-and-leisure-time
MVPA and BMI. Moreover, there were no differences between
BMI groups with regard to b-coefficients and risk of having
hypertension (Table 3).
The associations of commuting-and-leisure-time MVPA
with SBP and pulse pressure, but not DBP were age
dependent and stronger in older adults (test for interaction,
P<0.01; Figure 2A through 2C and Table S4). Moreover,
associations remained dose dependent over the age groups.
For example, the association between commuting-and-leisure-
time MVPA and pulse pressure was dose dependent and age
dependent as well (Figure 2C). b Coefficients (95% CI) for
lowest versus highest tertiles of commuting-and-leisure-time
MVPA were 0.29 (0.68 to 0.09) versus 0.56 (0.95 to
0.16), 0.91 (1.29 to 0.53) versus 1.69 (2.08 to
1.31) and 1.53 (2.68 to 0.38) versus 3.15 (4.22 to
2.10) mm Hg for SBP in adults <40, 40 to 60, and
>60 years, respectively. Furthermore, dose dependency was
observed in the association between MVPA and hypertension
risk in older age groups (>40 years; Figure 2D).
In the sensitivity analysis, similar dose-dependent associ-
ations as in the main analysis were observed in both
normotensive and hypertensive people (Table 4). The benefit
of commuting-and-leisure-time MVPA was virtually unchanged
after adjusting for antihypertensive medication use in hyper-
tensive people (10.8% users).
Unstandarized Beta (95%CI), mmHg SBP
ytivitcalacisyhP
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Figure 1. Association between domain-specific MVPA and BP.
A, SBP. B, DBP. Regression analysis between MVPA and BP
separately shown for SBP (A) and DBP (B). Determinants are
dummy variables of each domain. The dummy variables were
created for comparison between the reference group (T0) and
tertiles of MVPA (T1-3). Outcomes were presented as unstan-
dardized b coefficients with 95% CIs. Analysis adjusted for age,
square of age, sex, and education (basic model). BP indicates
blood pressure; CLTPA, commuting-and-leisure-time physical
activity; CPA, commuting physical activity; DBP, diastolic blood
pressure; LTPA, leisure-time physical activity; MVPA, moderate-to-
vigorous physical activity; OPA, occupational physical activity;
SBP, systolic blood pressure; TPA, total physical activity; T, tertile.
T0, T1, T2 and T3 indicate “inactive,: “not very active,” “active,”
and “very active” separately.
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Discussion
In line with previous studies, we found that an increased level
of physical activities in the leisure-time domain is associated
with lower BP or hypertension risk.2,3,8,9 Furthermore, among
domain-specific physical activities, the potential benefit of
daily-life physical activity on BP is most prominent for leisure-
time MVPA in our study. We also found a dose-response
relationship of leisure-time MVPA with BP and hypertension
risk, demonstrating that more physical activity is more
beneficial. Moreover, with regard to the dose dependency,
even a leisure-time MVPA level lower than the recommenda-
tion (>150 min/week),11,12 that is, the lowest level of MVPA
(MVPA-T1), was better than being entirely inactive (No MVPA)
in our study. Therefore, our large population-based study
supports the notion that increased daily-life physical activity,
especially in the leisure-time domain, is of fundamental
importance for the management of hypertension.11
Our study shows that not only physical activity during
leisure time, but also increased commuting MVPA may be a
way to improve the management of hypertension. It could be
an option for meeting the recommended level of daily-life
MVPA, and a combination of commuting and leisure-time
MVPA benefit BP more. Several but not all studies agree with
our findings.5,22,23 Treff et al5 (n=13 857) identified a positive
association between commuting physical activity and BP in
women. Lu et al22 (n=84 000) found no association between
commuting physical activity and BP. Kwasniewska et al23
(n=6401) concluded that increasing commuting physical
activity level may have an influence on reducing the preva-
lence of metabolic syndrome but is not associated with
physical activity parameters. Those inconsistent findings
Table 2. Associations of Commuting-and-Leisure-Time MVPA With BP and Hypertension Risk
Physical Activity
Unstandardized b (95% CI), mm Hg blood pressure
Basic Model Model 1 Model 2
A. SBP
CLTPA-T0 . . . . . . . . .
CLTPA -T1 1.55 (1.94 to 1.16)* 1.64 (2.03 to 1.24)* 0.99 (1.37 to 0.61)*
CLTPA -T2 2.17 (2.56 to 1.78)* 2.29 (2.68 to 1.90)* 1.27 (1.64 to 0.89)*
CLTPA -T3 2.75 (3.13 to 2.36)* 2.90 (3.29 to 2.50)* 1.68 (2.06 to 1.30)*
B. DBP
CLTPA-T0 . . . . . . . . .
CLTPA -T1 0.79 (1.04 to 0.55)* 0.85 (1.09 to 0.60)* 0.55 (0.79 to 0.31)*
CLTPA -T2 1.02 (1.27 to 0.78)* 1.11 (1.35 to 0.87)* 0.63 (0.87 to 0.39)*
CLTPA -T3 1.38 (1.63 to 1.14)* 1.49 (1.73 to 1.24)* 0.92 (1.16 to 0.68)*
C. Pulse pressure
CLTPA-T0 . . . . . . . . .
CLTPA -T1 0.76 (1.04; 0.48)* 0.79 (1.06; 0.51)* 0.42 (0.71; 0.17)†
CLTPA -T2 1.15 (1.42; 0.87)* 1.19 (1.46; 0.91)* 0.64 (0.91; 0.37)*
CLTPA -T3 1.36 (1.64; 1.09)* 1.41 (1.68; 1.13)* 0.76 (1.03; 0.49)*
D. Hypertension
Odds Ratio (95% CI)
Basic Model Model 1 Model 2
CLTPA-T0 1.0 1.0 1.0
CLTPA -T1 0.83 (0.78 to 0.88)* 0.82 (0.77 to 0.87)* 0.88 (0.83 to 0.94)†
CLTPA -T2 0.74 (0.70 to 0.79)* 0.73 (0.69 to 0.78)* 0.83 (0.78 to 0.88)*
CLTPA -T3 0.71 (0.66 to 0.75)* 0.69 (0.65 to 0.74)* 0.81 (0.76 to 0.86)*
Regression analyses between MVPA and BP or hypertension risk. Determinants are dummy exposure variables for commuting-and-leisure-time MVPA for comparison between the
reference group (No MVPA, T0) and tertiles of MVPA at each domain (T1-3). Data are expressed as unstandardized bcoefficient or odds ratio with 95% CI. Regression analyses for individual
domains are shown in Table S2. Basic model: age, square of age, sex, and education. Model 1: age, square of age, sex, education, smoking, and alcohol consumption. Model 2: age, square
of age, sex, education, smoking, alcohol consumption, and BMI. BMI indicates body mass index; BP, blood pressure; CLTPA, commuting-and-leisure-time physical activity; DBP, diastolic
blood pressure; MVPA, moderate-to-vigorous physical activity; SBP, systolic blood pressure; T, tertile.
*P<0.0001, †P<0.001.
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might be partly explained by the definition of commuting
physical activity. The above studies did not distinguish
intensity of commuting physical activity and included more
light-intensity physical activity like walking. For instance, Treff
et al5 included many noncycling participants in the assess-
ment of the commuting activity domain (91.8% of partici-
pants). We focused on only moderate-to-vigorous physical
activity during commuting, such as cycling or intense walking
(only brisk walking). Cycling was the major contributor to the
commuting domain (95.6% of all active commuters) in our
study. Laverty et al24 (n=20 458) also showed that more
vigorous forms of commuting physical activity are more
beneficial. Milett et al25 (n=3902) compared risk ratios for
mode of travel to work including walking, cycling, and private
and public transport, and showed that only cycling was
significantly associated with lower odds of hypertension after
adjustment for various confounders. Therefore, we conclude
that commuting physical activity at a more vigorous level is
associated with lower BP.
We did not find a beneficial effect of occupational
moderate-to-vigorous physical activity on BP and hyperten-
sion risk. In line with our results, a growing body of evidence
is showing that OPA has no benefit on health.4,6,7,26–29 For
instance, a meta-analysis of 13 prospective cohort studies
indicated that OPA is not beneficial in terms of protection
against hypertension.4 There was no significant association
of both moderate and high levels of occupational PA with risk
of hypertension compared with lower level of occupational
physical activity, while there was a dose-response risk
reduction of nonoccupational physical activity with hyperten-
sion in their pooled analysis. Moreover, Andersen and
Jensen29 reported that work-time activity had no effect on
population BP. In contrast to our findings, the EPIC-Florence
cohort found a significant inverse association between OPA
and DBP but not SBP.30 Fan et al10 identified a beneficial
effect of OPA in people with hypertension in relation to
cardiovascular mortality showing that higher OPA is associ-
ated with lower mortality risk. A renowned study of Morris
and Heady31 showed a significant difference in cardiovascu-
lar disease risk for “double-decker bus drivers” versus
“conductors who repeatedly walk up and down the bus
stairs frequently,” suggesting that a physically active occu-
pation is healthier than a sedentary type of occupation. Thus,
if physical activity at work requires more dynamic activities
with enough impact on cardiac output, it might have a
beneficial effect on health. However, most of the occupation-
related MVPA consists of heavy lifting or pushing and
extreme bending or twisting of the neck or back without
longer periods of rest for recovery.27 The types of occupa-
tions related to high occupational MVPA in our study
included occupations such as “metal, machinery, and related
trade work,” “handicraft and printing work,” and “other
mechanics and repairs.” Of course, there may be the
possibility of (residual) confounding by sex, work-related
stress, unhealthy environment with dust, inflammation, and
body weight. For instance, Holtermann et al32 found that
Table 3. Associations of MVPA With BP or Risk of Having Hypertension, According to BMI
BMI MVPA
Unstandardized b (95% CI), mm Hg Odds Ratio (95% CI)
SBP DBP Hypertension
<25 CLTPA-T0 . . . . . . 1.0
CLTPA-T1 1.00 (1.58 to 0.42)* 0.76 (1.13 to 0.39)† 0.85 (0.75 to 0.96)*
CLTPA-T2 1.11 (1.68 to 0.54)† 0.61 (0.98 to 0.25)* 0.84 (0.75 to 0.95)*
CLTPA-T3 1.74 (2.31 to 1.16)† 1.06 (1.43 to 0.70)† 0.80 (0.71 to 0.90)†
2530 CLTPA-T0 . . . . . . 1.0
CLTPA-T1 0.97 (1.58 to 0.37)* 0.38 (0.76 to 0.01) 0.88 (0.80 to 0.96)*
CLTPA-T2 1.65 (2.25 to 1.04)† 0.75 (1.14 to 0.37)† 0.80 (0.73 to 0.88)†
CLTPA-T3 1.97 (2.57 to 1.36)† 0.88 (1.27 to 0.50)† 0.77 (0.70 to 0.84)†
>30 CLTPA-T0 1.0
CLTPA-T1 1.45 (2.37 to 0.52)* 0.50 (1.07 to 0.07) 0.90 (0.79 to 1.02)
CLTPA-T2 1.69 (2.63 to 0.75)† 0.70 (1.28 to 0.12)‡ 0.77 (0.68 to 0.88)†
CLTPA-T3 1.33 (2.29 to 0.36)* 0.63 (1.22 to 0.03)‡ 0.85 (0.75 to 0.97)‡
Regression analysis between MVPA and BP or hypertension risk across different BMI level (<25, 25–30, and >30). Determinants are dummy exposure variables for each physical activity
domain for comparison between the reference group (No MVPA, T0) and tertiles of MVPA at each domain (T1-3). Data are expressed as bcoefficient or odds ratio with 95% CI. All analyses
adjusted for age, square of age, sex, education, smoking, and alcohol consumption. BMI, body mass index; BP, blood pressure; CLTPA, commuting-and-leisure-time physical activity; DBP,
diastolic blood pressure; MVPA, moderate-to-vigorous physical activity; SBP, systolic blood pressure; T, tertile.
*P<0.001, †P<0.0001, ‡P<0.05.
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occupational physical activity predicted all-cause mortality
and myocardial infarction in men but not in women (test for
interaction, P=0.02). We partly adjusted for confounders
such as sex, education, and BMI in our study. Taken
together, we suggest that it is important to be aware that
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Figure 2. Association of commuting-and-leisure-time MVPA with BP and hypertension risk, according to age. A, SBP. B, DBP. C, Pulse
pressure. D, Hypertension risk. Regression analysis for the association of commuting and leisure-time MVPA with blood pressure and
hypertension risk at different life stages (<40, 40–60, and >60) separately shown for SBP (A), DBP (B), and pulse pressure (C). Determinants
are dummy variables of MVPA. The dummy variables were created for comparison between the reference group (T0) and tertiles of MVPA (T1-
3). Outcomes were presented as unstandardized b coefficients and odds ratio with 95% CIs. Analysis adjusted for age, square of age, sex,
education, smoking, and alcohol consumption (Model 1). BP indicates blood pressure; DBP, diastolic blood pressure; MVPA, moderate-to-
vigorous physical activity; SBP, systolic blood pressure; T, tertile. T0 (black), T1 (white), T2 (light gray), and T3 (dark gray) indicate “inactive,”
“not very active,” “active,” and “very active” separately.
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for leisure-time MVPA or should not be considered a
measure of healthy daily-life physical activity.
In our study, the associations of daily-life MVPA with BP
and hypertension risk remained significant after adjusting for
BMI, showing that a beneficial effect of physical activity on BP
is independent of BMI. However, the associations attenuated
by 30% to 50% after adjustment. This might be explained by
the fact that obesity is a major risk factor for hypertension
and one way in which physical activity lowers BP through body
weight control.11,12 Furthermore, we show that the associa-
tion between MVPA and blood pressure is present, regardless
of BMI category. This is in line with previous studies.33,34 A
review of both observational and intervention studies showed
that higher baseline physical activity was associated with a
lower incidence of hypertension regardless of BMI, and that
increased physical activity reduced BP independently from
weight loss.33 A very recent meta-analysis of 24 prospective
cohort studies reported that there was no significant differ-
ence between overweight and normal-weight participants in
the association between physical activity and risk of hyper-
tension.34 In conclusion, our data support that the associa-
tions of MVPA with BP are partly mediated by BMI, but also
that higher MVPA can be related to lower BP independent of
BMI.
We found that the association of commuting-and-leisure-
time MVPA with systolic BP but not diastolic BP is age
dependent. This may partly be explained by age-related
changes in BP such as a steady increase in SBP and marked
decrease in DBP at older ages.35 Moreover, a stronger
association between MVPA and hypertension in older adults
might be related to an age-related increased risk for
hypertension in older adults.1,35 However, despite the strong
age-related effects, the dose dependency between MVPA and
BP or hypertension risk remained present over all age groups,
suggesting that more MVPA is more beneficial. For example, a
higher MVPA was also associated with pulse pressure in an
age- and dose-dependent manner in our study. Thus, we
suggest that active people at any age are more likely to have
healthier BP and lower hypertension risk.
The main strength of our study is its large sample size from
the general population, which allows us to estimate the effect
of major domains of daily-life physical activity on BP and risk
of having hypertension overall and in various subgroups by
age and by BMI categories with sufficient statistical power.
The Lifelines study population previously has been shown to
be representative of the population of the north of the
Netherlands, indicating that the risk of selection bias is low
and risk estimates can be generalized to the general
population.15 Furthermore, another strength is that measure-
ment of BP parameters was accurately performed with a
standard protocol. Using the last 3 of 10 readings of BP after
10 minutes’ rest in the supine position will have largely
avoided a white coat effect on readings of BP parameters.
However, there are some limitations to our study. A limitation
is our assessment of physical activity, which is based on self-
report and is subject to recall bias. However, the SQUASH is
validated in the general population with the Spearman
correlation coefficient for reproducibility of 0.58.17 Moreover,
other validation studies tested reproducibility of the ques-
tionnaire for men and women, for patients, and for multiethnic
Dutch people including various age groups. Results showed
high test-retest reliability scores between 0.6 and 0.8 within
intervals of 6 to 8 weeks.17,36,37 Another limitation is that we
could not control for the effect of salt intake, which can be a
confounder in the association of MVPA and BP. Furthermore,
our study design was cross sectional. It is, therefore, not
possible to rule out reverse causality. People with hyperten-
sion may have changed their physical activity behavior after
being told that they need to take antihypertensive medication.
The use of antihypertensives also influences BP recordings.
Table 4. Sensitivity Analysis for the Antihypertensive Medication Effect in the Association Between Commuting-and-Leisure-Time
MVPA and Pulse Pressure, According to Hypertensive Status
MVPA*
Unstandardized b (95% CI), mm Hg Pulse Pressure
Normotensive Subjects Hypertensive Subjects
Model 1 Model 1
Model 1 + Adjustment for
Antihypertensive Medication
CLTPA-T0 0 (Reference) 0 (Reference) 0 (Reference)
CLTPA-T1 0.35 (0.63 to 0.06)† 0.53 (1.01 to 0.42)† 0.55 (0.25 to 0.02)†
CLTPA-T2 0.59 (0.88 to 0.31)† 0.68 (1.16 to 0.20)† 0.70 (0.24 to 0.02)†
CLTPA-T3 0.62 (0.94 to 0.37)† 1.05 (1.53 to 0.57)† 1.13 (0.24 to 0.04)†
Stratified linear regression analysis between MVPA and pulse pressure. Data are expressed as standardized bcoefficients with 95% CI. Model 1 was adjusted for age, square of age, sex,
education, smoking, and alcohol consumption. CLTPA indicates commuting-and-leisure-time physical activity; MVPA, moderate-to-vigorous physical activity; T, tertile.
*Commuting-and-leisure-time.
†P<0.05.
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Therefore, we corrected the BP of people taking medication in
the main analysis and performed a sensitivity analysis using
uncorrected BP. In the sensitivity analysis, findings were
similar as in the main analysis.
Conclusions
To conclude, commuting and leisure-time MVPA, but not
occupational MVPA, were significantly associated with lower
BP and lower risk for hypertension over all ages and BMI
categories, with a stronger association in older adults. Taking
into account the differential association for occupational and
nonoccupational activities, we believe current guidelines for
the prevention of hypertension should indicate whether an
individual can reach the recommended level of MVPA in
different domains of daily-life activities, such as commuting
and occupational MVPA, or if this should be achieved by
leisure-time activities only. The present study suggests
focusing on leisure-time physical activity, but commuting
physical activity could also be included in the recommenda-
tion for daily-life physical activity if the commuting physical
activity is to be of the more vigorous kind. Also, when using
accelerometers, this aspect should be taken into considera-
tion when making interpretations. Furthermore, we suggest
that occupational MVPA should be evaluated more closely to
see when it can be considered as beneficial.
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Anthropometry and laboratory measurements 
Body height, weight, waist circumference, and blood pressure were measured by a 
fixed staff of well-trained research assistants using standardized protocols. Body weight was 
measured to the nearest 0.1 kg in light clothing and in the fasting state after urination. Height 
and waist circumference were measured to the nearest 0.5 cm. Height was measured with a 
wall-mounted stadiometer placing their heels against the rod and the head in Frankfort Plane 
position. Waist circumference was measured in standing position with a tape measure all 
around the body, at the level midway between the lower rib margin and the iliac crest.[1][2] 
The blood samples were collected in the fasting state, between 8.00 and 10.00 a.m. 
and analyzed on the day of collection at the Department of Laboratory Medicine of the 
University Medical Center Groningen, the Netherlands. Participants were requested to fast 
for at least 12 hours prior to the blood draw. Fasting blood glucose was measured by the 
hexokinase method. Serum levels of total and HDL cholesterol were measured using an 
enzymatic colorimetric method, triglycerides using a colorimetric UV method, and LDL-C 
using an enzymatic method, all on a Roche Modular P chemistry analyzer (Roche, Basel, 
Switzerland). [1][2] 
 
Definition of lifestyle confounders and diseases 
Education level: Education was categorized as low (no education, primary education, 
lower or preparatory vocational education and lower general secondary education), medium 
(intermediate vocational education or apprenticeship, higher general senior secondary 









Current smoking: Smoking status was categorized as non-smokers and smokers. 
Non-smokers were those who had not smoked during the last month and had also never 
smoked for longer than a year.  
Daily caloric intake and alcohol intake: Data on daily caloric and alcohol intake were 
collected from a food frequency questionnaire and presented as kilocalories a day (kcal/day) 
and grams of alcohol a day (gr/day). The calculation was based on intake frequency and the 
average number of units consumed on a day (divided the number of alcoholic drinks/week by 
7). In the Netherlands a standard unit contains 9.9 grams of alcohol. For each type of 
alcoholic beverage, respondents indicated whether they consumed it never (0%), sometimes 
(30%), often (70%) or always (100%).[1][2] 
Disease: Cardiovascular disease was assigned if participants self-reported one of the 
following disease symptoms to occur: heart failure, atrial fibrillation, vascular diseases 
(myocardial infarction, stroke, aneurysm) and used medications related to these symptoms 
(beta-blockers, angiotensin converting enzyme inhibitors, diuretics, vitamin K antagonist, 
statins, aspirin and clopidogrel). Information on diagnosis of renal failure was derived from a 
self-reported questionnaire. Type 2 diabetes mellitus (T2DM) was defined if participants who 
had self-reported T2DM or fasting blood glucose ≥ 7.0 mmol/L or HbA1c ≥ 6.5% or use of 
anti-T2D medication(s) or use of glucose-lowering agents (Anatomical therapeutic chemical 









Table S1. General characteristics of the study population, according to domain-
specific physical activity level. 
Variables 
Category of physical activity 
T0 T1 T2 T3 
TPA N 9.9 (12,408) 30.0 (37,665) 29.4 (36,904) 30.6 (38,425) 
 MVPA (min/week) 0 1-183 184-479 480-6840 
 Age (years) 45.89 ± 11.9 44.16 ± 12.1*** 44.06 ± 12.9*** 43.98 ± 12.7*** 
 Male sex, % (n) 45.1 (5,595) 35.8 (13,740)*** 38.1 (14,103)*** 45.9 (17,324) 
 Education: Low, % (n) 35.2 (4,363) 25.1 (9,626)*** 23.5 (8,653)*** 32.1 (12,116)** 
 Smoking, % (n) 32.6 (4,042) 20.7 (7,968)*** 17.3 (6,357)*** 21.7 (8,186)*** 
 Alcohol use, (gr/day) 2.92 (9.64) 3.38 (8.67)** 4.16 (8.94)*** 4.7 (10.31)*** 
 BMI (kg/m2) 27.1 ± 4.9 26.0 ± 4.3*** 25.6 ± 4.1*** 25.9 ± 4.2*** 
 Total cholesterol (mmol/L) 5.19  ± 1.02   5.07  ± 0.99***  5.05  ± 0.99***   5.07  ± 1.00***   
 Triglyceride (mmol/L) 1.35  ± 0.98  1.18  ± 0.84*** 1.12  ± 0.73*** 1.15  ± 0.77***  
 Diabetes, % (n) 5.1 (628) 3.1 (1,175)*** 2.6 (959)*** 2.7 (1,004)*** 
LTPA N 17.1 (21,387) 29.1 (36,456) 25.2 (31,607) 28.7 (35,952) 
 MVPA (min/week) 0 3-120 121-295 300-4200 
 Age (years) 44.23 ± 11.6 44.27 ± 12.3 44.33 ± 12.9 44.15 ± 13.1 
 Male sex, % (n) 46.6 (9,975) 37.8 (14,329)*** 36.9 (11,762)*** 43.0 (14,696)*** 
 Education: Low, % (n) 35.4 (7,573) 26.7 (10,129)*** 24.8 (7,895)*** 26.8 (9,161)*** 
 Smoking, % (n) 32.3 (6,912) 21.4 (8,100)*** 17.5 (5,595)*** 17.4 (5,946)*** 
 Alcohol use, (gr/day) 3.87 (9.90) 3.54 (8.66)*** 3.91 (8.61)*** 4.59 (8.93) 
 BMI (kg/m2) 26.8 ± 4.8 26.0 ± 4.3*** 25.8 ± 4.1*** 25.6 ± 4.0*** 
 Total cholesterol (mmol/L) 5.13  ± 1.00 5.08  ± 1.00*** 5.06  ± 0.99*** 5.06  ± 1.00*** 
 Triglyceride (mmol/L) 1.31  ± 0.94  1.18  ± 0.84*** 1.12  ± 0.74*** 1.11  ± 0.72***  
 Diabetes, % (n) 4.0 (850) 3.1 (1,180)*** 2.6 (839)*** 2.6 (897)*** 
CPA N 65.1 (81,587) 12.3 (15,399) 12.1(15,215) 10.5 (13,201) 
 MVPA (min/week) 0 1-50,0 51-120 122-1140 
 Age (years) 45.3 ± 12.6 42.67 ± 12.2*** 42.59 ± 11.8*** 41.89 ± 12.8*** 
 Male sex, % (n) 44.0 (35,862) 27.5 (4,049)*** 32.1 (4,771)*** 42.7 (6,080)** 
 Education: Low, % (n) 29.4 (24,027) 26.6 (3,922)*** 22.9 (3,405)*** 23.9 (3,404)*** 
 Smoking, % (n) 22.8 (18,367) 19.5 (2,875)*** 17.8 (2,645)*** 16.8 (2,396)*** 
 Alcohol use, (gr/day) 3.45 (10.29) 3.52 (9.03)*** 3.87 (8.87)*** 5.16 (9.96)* 
 BMI (kg/m2) 26.3 ± 4.3 25.5 ± 4.2*** 25.3 ± 4.2*** 25.3 ± 4.0*** 
 Total cholesterol (mmol/L) 5.12  ± 1.00 5.02  ± 0.98*** 5.01  ± 0.98*** 5.00  ± 1.00*** 
 Triglyceride (mmol/L) 1.22  ± 0.86  1.08  ± 0.67*** 1.08  ± 0.66*** 1.11  ± 0.73*** 
 Diabetes, % (n) 3.5 (2,868)*** 2.1 (303)*** 2.1 (305)*** 2.0 (290)*** 
OPA N 78.7 (98,752) 7.3 (9,103) 6.9 (8,661) 7.1 (8,886) 
 MVPA (min/week) 0 1-480 484-1348 1350-6720 
 Age (years) 45.13 ± 12.8 40.8 ± 11.8*** 41.01 ± 10.8*** 41.13 ±  10.7*** 
 Male sex, % (n) 39.0 (38,477) 39.4 (3,483) 35.3 (3,142)*** 63.5 (5,660)*** 
 Education: Low, % (n) 26.3 (25,983) 28.4 (2,504)*** 32.1 (2,859)*** 38.3 (3,412)*** 
 Smoking, % (n) 19.8 (19,520) 22.8 (2,012)*** 25.8 (2,292)*** 30.6 (2,729)*** 








 BMI (kg/m2) 25.9 ± 4.3 25.8 ± 4.3 26.1 ±  4.5*** 26.3 ± 4.2*** 
 Total cholesterol (mmol/L) 5.10  ± 1.00 4.96  ± 0.98*** 4.97  ± 0.97*** 5.01  ± 0.98*** 
 Triglyceride (mmol/L) 1.17  ± 0.81  1.16  ± 0.78 1.13  ± 0.70*** 1.25  ± 0.90*** 
 Diabetes, % (n) 3.2 (3,175) 2.3 (202)*** 2.2 (8,867) 2.2 (194) 
 
Data are presented as mean ± SD and number (percentages, %). MVPA are presented as minimum-
maximum. MVPA=moderate-to-vigorous physical activity, TPA=total physical activity, LTPA=leisure-
time PA, CPA=commuting PA, OPA=occupational PA, BMI=body mass index. The differences 
between groups were compared using ANOVA or the Mann-Whitney U test for continuous variables. 
The frequency distributions of categorical variables were analysed using the Pearson Chi-Square test. 
***Indicates a significant difference within each physical activity group relative to the reference group 
of inactive (T0); P value ≤ 0.000. **Indicates a significant difference within each physical activity group 
relative to the reference group of inactive (T0); P value ≤ 0.001. *Indicates a significant difference 









Table S2. Associations of domain-specific MVPA with blood pressure. 
Domains  MVPA 
Unstandardized beta (95% CI), mmHg 
Model 1 Model 2 
Systolic blood pressure 
 Commuting  CPA-T0 - - 
  CPA-T1 -1.57 (-1.93;-1.22)*** -0.96 (-1.30;-0.61)*** 
  CPA-T2 -1.65 (-2.00;-1.29)*** -0.91 (-1.25;-0.57)*** 
  CPA-T3 -1.65 (-2.03;-1.27)*** -0.94 (-1.30;-0.57)*** 
 Leisure-time LTPA-T0 - - 
  LTPA-T1 -1.25 (-1.60;-0.89)*** -0.66 (-1.01;-0.32)*** 
  LTPA-T2 -1.85 (-2.22;-1.49)*** -1.04 (-1.39;-0.69)*** 
  LTPA-T3 -2.25 (-2.61;-1.89)*** -1.27 (-1.61;-0.92)*** 
 Occupational  OPA-T0 - - 
  OPA-T1 0.10 (-0.28;0.48) 0.04 (-0.32; 0.41) 
  OPA-T2 -0.10 (-0.49;0.29) -0.32 (-0.69; 0.06) 
  OPA-T3 0.57 (0.18;0.97)** 0.40 (0.02; 0.78)* 
Diastolic blood pressure 
 Commuting  CPA-T0 - - 
  CPA-T1 -0.77 (-0.99;-0.54)*** -0.48 (-0.70;-0.26)*** 
  CPA-T2 -0.74 (-0.96;-0.52)*** -0.39 (-0.61;-0.18)*** 
  CPA-T3 -0.52 (-0.76;-0.28)*** -0.19 (-0.42; 0.05) 
 Leisure-time LTPA-T0 - - 
  LTPA-T1 -0.62 (-0.84;-0.39)*** -0.35 (-0.56;-0.13)** 
  LTPA-T2 -0.87 (-1.10;-0.64)*** -0.49 (-0.72;-0.27)*** 
  LTPA-T3 -1.23 (-1.46;-1.01)*** -0.77 (-0.99;-0.55)*** 
 Occupational  OPA-T0 - - 
  OPA-T1 0.21 (-0.03; 0.45) 0.19 (-0.05; 0.42) 
  OPA-T2 -0.21 (-0.46; 0.03) -0.32 (-0.55;-0.08)* 
  OPA-T3 -0.32 (-0.57;-0.07)* -0.40 (-0.64;-0.16)** 
Pulse pressure 
 Commuting  CPA-T0 - - 
  CPA-T1 -0.81 (-1.06;-0.56)*** -0.48 (-0.72;-0.23)*** 
  CPA-T2 -0.91 (-1.16;-0.66)*** -0.52 (-0.76;-0.27)*** 
  CPA-T3 -1.13 (-1.40;-0.86)*** -0.75 (-1.01;-0.49)*** 
 Leisure-time LTPA-T0 - - 
  LTPA-T1 -0.63 (-0.88;-0.38)*** -0.32 (-0.56;-0.07)* 
  LTPA-T2 -0.98 (-1.24;-0.72)*** -0.55(-0.80;-0.29)*** 
  LTPA-T3 -1.02 (-1.27;-0.77)*** -0.49 (-0.74;-0.25)*** 
 Occupational  OPA-T0 - - 
  OPA-T1 -0.11 (-0.38;0.16) -0.14 (-0.40; 0.12) 
  OPA-T2 0.12 (-0.16;0.39) 0.01(-0.27; 0.27) 
  OPA-T3 0.89 (0.61;1.17)** 0.80 (0.53; 1.07)* 
Regression analysis between domain-specific MVPA and blood pressure. Determinants are dummy exposure 
variables for each physical activity domain for comparison between the reference group (No MVPA, T0) and 
tertiles of MVPA at each domain (T1-3). Data are expressed as unstandardized beta coefficient with 95% 
confidence interval (95% CI). MVPA=moderate-to-vigorous physical activity, CPA=commuting PA, LTPA=leisure-
time PA, OPA=occupational PA, T=tertile.  
Model 1: age, age2, sex, education, smoking and alcohol consumption 
Model 2: age, age2, sex, education, smoking and alcohol consumption and  BMI 









Table S3. Associations of domain-specific MVPA with risk of having hypertension. 
Domains  MVPA 
Odds Ratio (95%CI) 
Basic Model Model 1 Model 2 
Commuting  CPA-T0 1.0 1.0 1.0 
 CPA-T1 0.81 (0.76; 0.87)*** 0.81 (0.76; 0.86)*** 0.86 (0.81; 0.92)*** 
 CPA-T2 0.81 (0.76; 0.86)*** 0.80 (0.76; 0.86)*** 0.87 (0.81; 0.92)*** 
 CPA-T3 0.78 (0.73; 0.84)*** 0.78 (0.73; 0.83)*** 0.84 (0.78; 0.90)*** 
Leisure-time LTPA-T0 1.0 1.0 1.0 
 LTPA-T1 0.86 (0.82; 0.92)*** 0.86 (0.81; 0.91)*** 0.92 (0.87; 0.98)** 
 LTPA-T2 0.76 (0.73; 0.82)*** 0.76 (0.72; 0.81)*** 0.85 (0.80; 0.90)*** 
 LTPA-T3 0.76 (0.71; 0.80)*** 0.74 (0.70; 0.79)*** 0.85 (0.80; 0.90)*** 
Occupational  OPA-T0 1.0 1.0 1.0 
 OPA-T1 1.00 (0.94; 1.07) 1.00 (0.94; 1.07) 0.99 (0.92; 1.06) 
 OPA-T2 0.99 (0.93; 1.06) 0.99 (0.93; 1.06) 0.96 (0.90; 1.03) 
 OPA-T3 1.06 (0.99; 1.13) 1.05 (0.98; 1.12) 1.00 (0.97; 1.11) 
Logistic regression analysis between domain-specific MVPA and hypertension risk. Determinants are reference 
group (No MVPA, T0) and tertiles of MVPA at each domain (T1-3). Data are expressed as odds ratio with 95% 
confidence interval (95% CI). MVPA=moderate-to-vigorous physical activity, CPA=commuting PA, LTPA=leisure-
time PA, OPA=occupational PA, T=tertile.  
Basic model: age, age2, sex and education 
Model 1: age, age2, sex, education, smoking and alcohol consumption 
Model 2: age, age2, sex, education, smoking, alcohol consumption and BMI 








Table S4. Associations of domain-specific MVPA with blood pressures (by age). 
Age MVPA 






<40 Commuting                    
 CPA-T1 -0.94 (-1.41;-0.48)***  -0.54 (-0.86;-0.53)**  -0.40 (-0.75;-0.05)* 
 CPA-T2 -1.50 (-1.97;-1.03)***  -0.85 (-1.16;-0.23)***  -0.66 (-1.00;-0.31)*** 
 CPA-T3 -1.57 (-2.04;-1.11)***  -0.55 (-0.86;-0.07)*  -1.02 (-1.37;-0.68)*** 
 Leisure-time                   
 LTPA-T1 -0.69 (-1.16;-0.23)***  -0.38 (-0.69;-0.07)*  -0.31 (-0.66; 0.03) 
 LTPA-T2 -1.16(-1.64;-0.68)***  -0.68 (-1.01;-0.36)***  -0.47 (-0.83;-0.11)* 
 LTPA-T3 -1.25 (-1.73;-0.78)***  -0.87 (-1.19;-0.55)***  -0.38 (-0.74;-0.02)* 
 Occupational          
 OPA-T1 -0.04 (-0.51; 0.43)  0.10 (-0.21; 0.42)  -0.15 (-0.50; 0.20) 
 OPA-T2 0.45 (-0.04; 0.93)  -0.12 (-0.44; 0.21)  0.57 (0.21; 0.93)** 
 OPA-T3 0.91 (0.45; 1.37)**  -0.18 (-0.49; 0.14)  1.08 (0.74; 1.43)** 
40-60 Commuting                   
 CPA-T1 -1.57 (-2.10;-1.04)***  -0.87 (-1.20;-0.53)***  -0.70 (-1.06;-0.34)*** 
 CPA-T2 -1.68 (-2.19;-1.16)***  -0.76 (-1.09;-0.43)***  -0.91 (-1.26;-0.57)*** 
 CPA-T3 -1.53 (-2.07;-0.98)***  -0.73 (-1.07;-0.38)***  -0.80 (-1.17;-0.43)*** 
 Leisure-time                   
 LTPA-T1 -1.52 (-2.02;-1.01)***  -0.77 (-1.09;-0.45)***  -0.74 (-1.09;-0.40)*** 
 LTPA-T2 -2.29 (-2.81;-2.20)***  -1.05 (-1.38;-0.71)***  -1.24 (-1.60;-0.88)*** 
 LTPA-T3 -2.72 (-3.25;-1.10)***  -1.37 (-1.70;-1.04)***  -1.36 (-1.71;-1.01)*** 
 Occupational          
 OPA-T1 0.42 (-0.16; 0.99)  0.22 (-0.14; 0.58)  0.20 (-0.09; 0.58) 
 OPA-T2 0.25 (-0.81; 0.31)  -0.36 (-0.71;-0.01)  0.11 (-0.27; 0.49) 
 OPA-T3 0.02 (0.57; 0.60)*  -0.52 (-0.88;-0.15)*  0.53 (0.14; 0.93)* 
>60 Commuting                   
 CPA-T1 -3.77 (-5.29;-2.25)**  -1.23 (-2.05;-0.41)**  -2.54 (-3.61;-1.47)*** 
 CPA-T2 -1.85 (-3.56;-0.15)*  -0.61 (-1.53; 0.31)  -1.24 (-2.44;-0.04)* 
 CPA-T3 -2.31 (-3.99;-0.64)*  -0.89 (-1.79; 0.01)  -1.42 (-2.60;-0.25)* 
 Leisure-time                   
 LTPA-T1 -1.59 (-3.08;-0.10)*  -0.43 (-1.24; 0.37)  -1.15 (-2.20;-0.11)* 
 LTPA-T2 -3.40 (-4.89;-1.90)***  -0.75 (-1.56; 0.06)  -2.65(-3.70;-1.59)*** 
 LTPA-T3 -3.76 (-5.24;-2.28)***  -1.17 (-1.97;-0.37)**  -2.59 (-3.63;-1.55)*** 
 Occupational       
 OPA-T1 0.52 (-0.15; 2.18)  0.62 (-0.64; 1.16)  0.26 (-0.91; 1.43) 
 OPA-T2 -1.42 (-4.09; 1.24)  -0.78 (-2.22; 0.65)  -0.64 (-2.51; 1.24) 
 OPA-T3 1.42 (-1.74; 4.55)*  1.11 (-0.59; 2.80)*  0.30 (-1.91; 2.51)* 
Regression analysis between domain-specific MVPA and blood pressure at different life stages (<40, 
40-60 and >60). Determinants are dummy variables of MVPA. The dummy variables were created for 
comparison between the reference group (T0) and tertiles of MVPA (T1-3). Outcomes were presented 
as unstandardized beta-coefficients with 95% confidence intervals (95%CI). Analysis adjusted for age, 
age2, sex, education, smoking and alcohol consumption (Model 1). MVPA=moderate-to-vigorous 
physical activity, T=tertile, BP=blood pressure, CPA=commuting PA, LTPA=leisure-time PA, 


































Figure S3. Level of daily-life physical activity according to age. 
 
 
MVPA (min/week) are expressed as adjusted means (adjusted for age, sex, education) for total and 
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